Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Phase 1b Safety and Preliminary Efficacy of Bilateral Intraputaminal Delivery of AAV2 GDNF (AB-1005) in Participants With Mild or Moderate Parkinson’s Disease

              Author:Van Laar, Amber   Christine, Chadwick   Merola, Aristide   Phielipp, Nicolás   Elder, Bradley   Larson, Paul   San Sebastian, Waldy   Fiandaca, Massimo   Kells, Adrian   Bankiewicz, Krystof   

              Session Name:N2: Neuroscience in the Clinic: Neuromodulation: From Bench to Bedside  

              Topic:Movement Disorders  

              Program Number:N2.001  

              Author Institution:Asklepios BioPharmaceutical, Inc., Durham, NC  University of California San Francisco, San Francisco, CA  The Ohio State University, Columbus, OH  University California, Irvine Health, Irvine, CA  University of Arizona College of Medicine, Tucson, AZ